{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:47:18Z","timestamp":1793314038141,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,24]]},"DOI":"10.7759\/cureus.82885","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T08:21:28Z","timestamp":1745482888000},"source":"Crossref","is-referenced-by-count":5,"title":["Chemotherapy-Induced Mucositis in Pediatric Oncology: Experience From 145 Cases at the Mohammed VI University Hospital, Oujda"],"prefix":"10.7759","author":[{"given":"Hanae","family":"Bahari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayad","family":"Ghanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanane","family":"Hajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Elouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdeladim","family":"Babakhouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rkain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2050","article-title":"Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation","volume":"32","author":"Bezinelli LM","year":"2014","unstructured":"Bezinelli LM, de Paula Eduardo F, da Gra\u00e7a Lopes RM, et al.. Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation. Hematol Oncol. 2014, 32:31-9. 10.1002\/hon.2050","journal-title":"Hematol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04848-4","article-title":"Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines","volume":"27","author":"Hong CH","year":"2019","unstructured":"Hong CH, Gueiros LA, Fulton JS, et al.. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019, 27:3949-67. 10.1007\/s00520-019-04848-4","journal-title":"Support Care Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40368-022-00727-5","article-title":"Chemotherapy-induced oral mucositis in children and adolescents: a systematic review","volume":"23","author":"Docimo R","year":"2022","unstructured":"Docimo R, Anastasio MD, Bensi C. Chemotherapy-induced oral mucositis in children and adolescents: a systematic review. Eur Arch Paediatr Dent. 2022, 23:501-11. 10.1007\/s40368-022-00727-5","journal-title":"Eur Arch Paediatr Dent"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13863","article-title":"Risk factors associated with the development of oral mucositis in pediatric oncology patients: systematic review and meta-analysis","volume":"28","author":"de Farias Gabriel A","year":"2022","unstructured":"de Farias Gabriel A, Silveira FM, Curra M, et al.. Risk factors associated with the development of oral mucositis in pediatric oncology patients: systematic review and meta-analysis. Oral Dis. 2022, 28:1068-84. 10.1111\/odi.13863","journal-title":"Oral Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.31486\/toj.18.0061","article-title":"Dental care for patients with childhood cancers","volume":"18","author":"Ritwik P","year":"2018","unstructured":"Ritwik P. Dental care for patients with childhood cancers. Ochsner J. 2018, 18:351-7. 10.31486\/toj.18.0061","journal-title":"Ochsner J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2018.03.014","article-title":"A review of clinical radioprotection and chemoprotection for oral mucositis","volume":"11","author":"Oronsky B","year":"2018","unstructured":"Oronsky B, Goyal S, Kim MM, et al.. A review of clinical radioprotection and chemoprotection for oral mucositis. Transl Oncol. 2018, 11:771-8. 10.1016\/j.tranon.2018.03.014","journal-title":"Transl Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv202","article-title":"Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up","volume":"26 Suppl 5","author":"Peterson DE","year":"2015","unstructured":"Peterson DE, Boers-Doets CB, Bensadoun RJ, Herrstedt J. Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2015, 26 Suppl 5:v139-51. 10.1093\/annonc\/mdv202","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis ST","year":"2004","unstructured":"Sonis ST, Elting LS, Keefe D, et al.. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004, 100:1995-2025. 10.1002\/cncr.20162","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2010.03.012","article-title":"Oral mucositis","volume":"46","author":"Raber-Durlacher JE","year":"2010","unstructured":"Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol. 2010, 46:452-6. 10.1016\/j.oraloncology.2010.03.012","journal-title":"Oral Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2009.08.006","article-title":"Mucositis: the impact, biology and therapeutic opportunities of oral mucositis","volume":"45","author":"Sonis ST","year":"2009","unstructured":"Sonis ST. Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009, 45:1015-20. 10.1016\/j.oraloncology.2009.08.006","journal-title":"Oral Oncol"},{"key":"ref11","article-title":"Prevalence and management of chemo-induced gastrointestinal side effects in children aged 0 to16 years at the CHU Donka","volume":"24","author":"Diop MM","year":"2023","unstructured":"Diop MM, Barry A, Camara E, et al.. Prevalence and management of chemo-induced gastrointestinal side effects in children aged 0 to16 years at the CHU Donka. Health Sci Dis. 2023, 24:153-6.","journal-title":"Health Sci Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.23804\/ejpd.2018.19.03.13","article-title":"Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series","volume":"19","author":"Garrocho-Rangel JA","year":"2018","unstructured":"Garrocho-Rangel JA, Herrera-Moncada M, M\u00e1rquez-Preciado R, Tejeda-Nava F, Ortiz-Zamudio JJ, Pozos-Guill\u00e9n A. Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series. Eur J Paediatr Dent. 2018, 19:239-42. 10.23804\/ejpd.2018.19.03.13","journal-title":"Eur J Paediatr Dent"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.12.009","article-title":"Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients","volume":"94","author":"Kuiken NS","year":"2015","unstructured":"Kuiken NS, Rings EH, Tissing WJ. Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients. Crit Rev Oncol Hematol. 2015, 94:87-97. 10.1016\/j.critrevonc.2014.12.009","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.paed.2013.10.007","article-title":"Symptom management during chemotherapy","volume":"24","author":"McCulloch R","year":"2014","unstructured":"McCulloch R, Hemsley J, Kelly P. Symptom management during chemotherapy. Paediatr Child Health. 2014, 24:166-71. 10.1016\/j.paed.2013.10.007","journal-title":"Paediatr Child Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.02.010","article-title":"Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0","volume":"67","author":"Chen AP","year":"2012","unstructured":"Chen AP, Setser A, Anadkat MJ, Cotliar J, Olsen EA, Garden BC, Lacouture ME. Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. J Am Acad Dermatol. 2012, 67:1025-39. 10.1016\/j.jaad.2012.02.010","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000970","article-title":"The prevalence and investigation of risk factors of oral mucositis in a pediatric oncology inpatient population: a prospective study","volume":"40","author":"Allen G","year":"2018","unstructured":"Allen G, Logan R, Revesz T, Keefe D, Gue S. The prevalence and investigation of risk factors of oral mucositis in a pediatric oncology inpatient population: a prospective study. J Pediatr Hematol Oncol. 2018, 40:15-21. 10.1097\/MPH.0000000000000970","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002392","article-title":"Factors associated with oral mucositis severity in children who have received chemotherapy","volume":"44","author":"Hurrell L","year":"2022","unstructured":"Hurrell L, Burgoyne LL, Logan RM, Revesz T, Gue S. Factors associated with oral mucositis severity in children who have received chemotherapy. J Pediatr Hematol Oncol. 2022, 44:e1016-22. 10.1097\/MPH.0000000000002392","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad S","year":"2020","unstructured":"Elad S, Cheng KK, Lalla RV, et al.. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020, 126:4423-31. 10.1002\/cncr.33100","journal-title":"Cancer"},{"key":"ref19","unstructured":"Oral Complications of Cancer Therapies (PDQ\u00ae)-Health Professional Version. (2024). Accessed. February 16, 2024: https:\/\/www.cancer.gov\/about-cancer\/treatment\/side-effects\/mouth-throat\/oral-complications-hp-pdq."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359580-chemotherapy-induced-mucositis-in-pediatric-oncology-experience-from-145-cases-at-the-mohammed-vi-university-hospital-oujda","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T08:21:31Z","timestamp":1745482891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359580-chemotherapy-induced-mucositis-in-pediatric-oncology-experience-from-145-cases-at-the-mohammed-vi-university-hospital-oujda"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.82885","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}